
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.020 | 5.020 | 0.000 |
Shares | 94.980 | 94.980 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.939 | 19.991 |
Price to Book | 4.565 | 3.937 |
Price to Sales | 2.962 | 2.312 |
Price to Cash Flow | 16.249 | 15.597 |
Dividend Yield | 2.173 | 1.427 |
5 Years Earnings Growth | 9.366 | 11.176 |
Number of long holdings: 36
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 7.67 | 95.08 | +1.12% | |
Merck & Co Inc | - | 6.34 | - | - | |
AstraZeneca | GB0009895292 | 5.89 | 10,574.0 | -1.36% | |
Edwards Lifesciences Corp | - | 4.97 | - | - | |
Novo Nordisk A/S B | DK0060534915 | 4.90 | - | - | |
Roche Holding Participation | CH0012032048 | 4.77 | 264.70 | -0.30% | |
Boston Scientific Corp | - | 4.65 | - | - | |
Eli Lilly and Co | - | 4.49 | - | - | |
Medtronic | IE00BTN1Y115 | 4.42 | 83.07 | +0.10% | |
Pfizer Inc | - | 3.97 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IKC Taktisk Allokering 0 100 | 4.86B | -12.43 | 2.49 | 6.81 | ||
IKC Sverige Flexibel | 2.03B | -2.58 | 0.15 | 10.43 | ||
IKC Fastighetsfond A | 625.64M | -5.17 | -5.80 | 7.50 | ||
IKC Fastighetsfond B | 625.64M | -5.07 | -5.45 | 7.93 | ||
IKC 0 100 | 496.35M | -0.31 | 7.33 | 8.12 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review